$29.38
1.87% yesterday
Nasdaq, Jun 27, 10:03 pm CET
ISIN
US68213N1090
Symbol
OMCL

Omnicell, Inc. Stock price

$29.38
-0.23 0.78% 1M
-14.68 33.32% 6M
-15.14 34.01% YTD
+3.11 11.84% 1Y
-94.71 76.32% 3Y
-39.27 57.20% 5Y
-8.11 21.63% 10Y
+22.12 304.68% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
+0.54 1.87%
ISIN
US68213N1090
Symbol
OMCL
Sector
Industry

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.3b
Net debt
$-82.6m
Cash
$423.8m
Shares outstanding
46.8m
Valuation (TTM | estimate)
P/E
65.29 | 23.56
P/S
1.21 | 1.19
EV/Sales
1.14 | 1.12
EV/FCF
12.03
P/B
1.09
Financial Health
Equity Ratio
58.62%
Return on Equity
1.01%
ROCE
0.68%
ROIC
0.44%
Debt/Equity
0.27
Financials (TTM | estimate)
Revenue
$1.1b | $1.2b
EBITDA
$100.9m | $112.7m
EBIT
$10.6m
Net Income
$21.2m | $58.4m
Free Cash Flow
$107.5m
Growth (TTM | estimate)
Revenue
3.00% | 3.84%
EBITDA
52.64% | 18.36%
EBIT
151.63%
Net Income
201.10% | 366.16%
Free Cash Flow
-34.65%
Margin (TTM | estimate)
Gross
43.24%
EBITDA
8.88% | 9.76%
EBIT
0.93%
Net
1.87% | 5.06%
Free Cash Flow
9.47%
More
EPS
$0.45
FCF per Share
$2.30
Short interest
7.51%
Employees
3.67k
Rev per Employee
$300.00k
Show more

Is Omnicell, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Omnicell, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Omnicell, Inc. forecast:

10x Buy
67%
5x Hold
33%

Analyst Opinions

15 Analysts have issued a Omnicell, Inc. forecast:

Buy
67%
Hold
33%

Financial data from Omnicell, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,136 1,136
3% 3%
100%
- Direct Costs 645 645
2% 2%
57%
491 491
4% 4%
43%
- Selling and Administrative Expenses 390 390
2% 2%
34%
- Research and Development Expense 89 89
4% 4%
8%
101 101
53% 53%
9%
- Depreciation and Amortization 90 90
4% 4%
8%
EBIT (Operating Income) EBIT 11 11
152% 152%
1%
Net Profit 21 21
201% 201%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Omnicell, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Omnicell, Inc. Stock News

Neutral
Business Wire
about one month ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program.
Neutral
Business Wire
about one month ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces New Products for Perioperative and Clinic Settings.
Neutral
Business Wire
about one month ago
AUSTIN, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced the opening of its Innovation Lab, located at 1005 East St. Elmo Road in Austin, Texas. The facility will serve as a hub focused on addressing challenges along the medication and supply journey and developing new tech...
More Omnicell, Inc. News

Company Profile

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Head office United States
CEO Randall Lipps
Employees 3,670
Founded 1992
Website www.omnicell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today